Published in Heart on December 18, 2013
Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med (2008) 3.21
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation (2009) 2.09
Pulsatile venoarterial perfusion using a novel synchronized cardiac assist device augments coronary artery blood flow during ventricular fibrillation. Artif Organs (2014) 1.99
CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol (2012) 1.92
How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention (2011) 1.78
Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology (2006) 1.57
Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension (2012) 1.54
The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation. Eur Heart J (2011) 1.51
Inhibition of neo-intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel-coated scoring balloon catheter. Catheter Cardiovasc Interv (2013) 1.46
Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost (2009) 1.46
Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent. Catheter Cardiovasc Interv (2013) 1.44
High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study. J Endovasc Ther (2013) 1.39
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol (2010) 1.27
SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J Am Coll Cardiol (2012) 1.13
Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study. EuroIntervention (2012) 1.12
Drug-Coated Balloon Treatment as Default Strategy for DES-ISR. J Am Coll Cardiol (2016) 1.07
Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. Clin Res Cardiol (2014) 1.07
Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel? Circ Cardiovasc Interv (2012) 1.05
Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Circ Res (2003) 1.05
Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis. Eur Heart J (2010) 0.97
Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol (2013) 0.92
Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest Radiol (2011) 0.91
Prevention of restenosis: is angioplasty the answer? Heart (2007) 0.87
Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol (2009) 0.86
Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells. EuroIntervention (2011) 0.85
Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI! Clin Res Cardiol (2010) 0.84
Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol (2007) 0.84
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months? EuroIntervention (2013) 0.83
Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis. Coron Artery Dis (2009) 0.83
Long-term follow-up of early versus delayed invasive approach after fibrinolysis in acute myocardial infarction. Circ Cardiovasc Interv (2011) 0.81
Hotline update of clinical trials and registries presented at the ACC and SCAI-ACCi2 meeting 2008 in Chicago. Clin Res Cardiol (2008) 0.80
Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter. Clin Res Cardiol (2012) 0.80
Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis. Clin Res Cardiol (2013) 0.79
Drug-coated balloons--the new gold standard for treatment of coronary in-stent restenosis? Cardiovasc Revasc Med (2012) 0.79
Inhibition of restenosis in stented porcine coronary arteries: uptake of Paclitaxel from angiographic contrast media. Invest Radiol (2004) 0.79
Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease. Basic Res Cardiol (2009) 0.79
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study. EuroIntervention (2015) 0.78
Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis. Catheter Cardiovasc Interv (2012) 0.78
PCI in small vessels: the case for a drug-coated balloon based intervention. EuroIntervention (2011) 0.78
Drug delivery by angiographic contrast media: inhibition of restenosis. Acad Radiol (2005) 0.78
Evaluation of a newly designed flow diverter for the treatment of intracranial aneurysms in an elastase-induced aneurysm model, in New Zealand white rabbits. Neuroradiology (2014) 0.78
Evaluation of a newly designed flow diverter for the treatment of intracranial aneurysms in an elastase-induced aneurysm model, in New Zealand white rabbits. Neuroradiology (2013) 0.77
Thrombus Aspiration in ThrOmbus containing culpRiT lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI): study protocol for a randomized controlled trial. Trials (2013) 0.76
New technologies in percutaneous coronary interventions: drug-coated balloons. EuroIntervention (2011) 0.75
Inhibition of neointimal proliferation after bare metal stent implantation with low-pressure drug delivery using a paclitaxel-coated balloon in porcine coronary arteries. Clin Res Cardiol (2012) 0.75
Management of recurrent in-stent restenosis: onion skin full metal jacket? EuroIntervention (2013) 0.75
Local drug delivery - the early Berlin experience: single drug administration versus sustained release. EuroIntervention (2011) 0.75
How does a drug-coated balloon work? Overview of coating techniques and their impact. J Cardiovasc Surg (Torino) (2016) 0.75
No difference among modern contrast media's effect on neointimal proliferation and restenosis after coronary stenting in pigs. Invest Radiol (2003) 0.75
State of the art: balloon catheter technologies - drug-coated balloon. EuroIntervention (2017) 0.75
Paradigms and perspectives in contrast media research. Acad Radiol (2002) 0.75
[Update cardiology 2006/2007]. Med Klin (Munich) (2007) 0.75
From bench to Paccocath. EuroIntervention (2011) 0.75
A Novel Constrained, Paclitaxel coated Angioplasty Balloon Catheter. EuroIntervention (2016) 0.75